JohnR.WeisMD
Oncology • Minneapolis, MNAssistant Professor, Internal Medicine, University of Utah School of Medicine
Dr. Weis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11850 Blackfoot St NW
Minneapolis, MN 55433Phone+1 763-236-0808Fax+1 763-236-6065
Education & Training
University of Utah HealthFellowship, Hematology and Medical Oncology, 1988 - 1991- University of Utah HealthResidency, Internal Medicine, 1984 - 1987
University of Minnesota Medical SchoolClass of 1984
Certifications & Licensure
UT State Medical License 1985 - 2026
MN State Medical License 2021 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors.Yoon-Koo Kang, Min-Hee Ryu, Yong Sang Hong, Chang-Min Choi, Tae Won Kim
Cancer Research and Treatment. 2024-07-01 - 9 citationsDiscrepancies between tumor genomic profiling and germline genetic testing.K Pauley, C Koptiuch, S Greenberg, W Kohlmann, J Jeter
ESMO Open. 2022-08-01 - 29 citationsA Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.Kristen C. Kelley, Kenneth Grossman, Mary Brittain-Blankenship, Kelli M. Thorne, Wallace Akerley
BMC Cancer. 2021-05-07
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
